SCHEMBL23735874

SCHEMBL23735874

CCc1cccc(C#N)c1C(C)C

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 1/20 0.38
GABRA1 P14867 4/20 0.38
GABRB2 P47870 4/20 0.38
KDM5A P29375 1/20 0.38
TSHR P16473 4/20 0.36
LRRK2 Q5S007 1/20 0.35
MAPK1 P28482 1/20 0.35
AR P10275 1/20 0.35
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28044155 0.86 GABRA1 (0.39) L3MBTL1SMN1; SMN2LMNAGABRA1GABRB2
SCHEMBL15417412 0.84 TSHR (0.38) L3MBTL1SMN1; SMN2GABRA1GABRB2TSHR
SCHEMBL807524 0.82 TSHR (0.46) L3MBTL1SMN1; SMN2KDM5ATSHRLRRK2
SCHEMBL9734348 0.80 GABRA1 (0.50) L3MBTL1SMN1; SMN2LMNAGABRA1GABRB2
SCHEMBL21736887 0.78 HTR2A (0.34) SMN1; SMN2KDM5ATSHRLRRK2MAPK1
SCHEMBL21728161 0.77 DRD2 (0.32) TSHRSLC6A2SLC6A4
SCHEMBL106062 0.76 TSHR (0.50) L3MBTL1SMN1; SMN2GABRA1GABRB2TSHR
SCHEMBL13778070 0.75 TSHR (0.43) L3MBTL1SMN1; SMN2LMNAGABRA1GABRB2
SCHEMBL7790350 0.75 GABRA1 (0.41) LMNAGABRA1GABRB2KDM5ATSHR
SCHEMBL13377164 0.75 GABRA1 (0.41) L3MBTL1SMN1; SMN2LMNAGABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3814331-B1 NOVEL LXR MODULATORS WITH BICYCLIC CORE MOIETY ORSOBIO INC (US) 2023-06-14 EP disclosed
EP-3558955-B1 BENZISOTHIAZOLE, ISOTHIAZOLO[3,4-B]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-D]PYRIDAZINE AND PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG, PANCREATIC OR COLORECTAL CANCER AMGEN INC (US) 2021-08-11 EP disclosed